PROJECT DETAILS
Therapeutic Area
Oncology / Cell & Gene Therapy
Timeline
Accelerated Approval Cycle
Deliverables
5-Piece Toolkit
Capabilities
Launch Readiness, Billing & Coding, KOL Engagement
Launch Excellence
Market Access
Cell & Gene Therapy
Accelerated Access Toolkit for First-in-Class Cell Therapy
Delivering a comprehensive HCP billing and access toolkit under accelerated approval timelines—empowering treatment centers to operationalize a pioneering oncology cell therapy from day one.
🧬
Cell Therapy Launch Excellence
KOL
Co-Developed
Under
Budget
On Time
Delivery
5
Toolkit Components
the challenge
Complex Therapy, Compressed Timeline
A biopharma company was launching a highly complex, first-in-class oncology cell therapy under accelerated FDA approval. The therapy required intricate administration protocols, specialized treatment center certification, and novel reimbursement pathways that didn't fit existing billing frameworks.
Previous efforts from other agencies had failed to deliver effective HCP and billing resources, leaving the commercial team without the tools needed to support treatment centers. With approval imminent and competitors preparing their own launches, the company needed to rapidly develop a comprehensive access toolkit.
"Treatment centers needed actionable resources from day one—not theoretical frameworks, but practical tools they could immediately use to get patients treated."
Our Approach
KOL-Centered Accelerated Development
We deployed an accelerated, KOL-centered development process that prioritized real-world usability over theoretical completeness.
01
KOL Co-Development
Engaged physician and pharmacist key opinion leaders from the start, ensuring every resource reflected actual clinical workflows and billing realities.
02
Parallelized Development
Created materials iteratively while gathering real-world user feedback, compressing timelines without sacrificing quality.
03
Streamlined MLR Review
Collaborated closely with legal counsel to anticipate and address medical/legal/regulatory concerns proactively, avoiding review bottlenecks.
04
Field Team Integration
Built resources that payer account teams could immediately deploy, with clear talking points and objection handlers.
"
The toolkit empowered HCPs and pharmacy reimbursement teams with vital resources to understand, access, and operationalize this pioneering cell therapy.
Project Lead
the results
Launch-Ready from Day One
The toolkit launched on time with FDA approval, equipping certified treatment centers with the resources they needed immediately.
🏥
Ready
Operational readiness for treatment centers from launch
⏱️
On Time
Delivered complete toolkit synchronized with FDA approval
💰
Under
Budget through streamlined development process
key insights
Launch Excellence Best Practices
1
KOL Input From Day One
Engaging clinical experts early ensures resources reflect real-world workflows rather than theoretical frameworks.
2
Parallel Development Compresses Timelines
Iterative creation with continuous feedback avoids the delays of sequential waterfall approaches.
3
Proactive MLR Engagement
Working with legal early prevents review bottlenecks that can derail launch timelines.
4
Field Team Enablement Is Critical
Even the best toolkit fails without practical deployment guidance for account teams.
Ready to Launch?
Let's discuss how we can support your market access strategy for complex therapies.